BAKX Therapeutics, a company developing safer, more effective therapeutics that fully realize the potential of the mitochondrial apoptosis pathway, announced Marina Konopleva, M.D., Ph.D., Albert Einstein College of Medicine joined the company’s Scientific Advisory Board.
November 16, 2022
· 3 min read